[302 Pages Report] Bioprocessing Analytics Equipment Market revenue is set to total US$ 485.1 Mn in 2022. The global market is expected to reach US$ 633.6 Mn by 2028, rising at a CAGR of 4.5%.
Attribute | Details |
---|---|
Global Bioprocessing Analytics Equipment Market Size (2022) | US$ 485.1 million |
Predicted Market Value (2028) | US$ 633.6 million |
Forecasted Growth Rate (2022-2028) | 4.3% CAGR |
Region with Highest Market Share | North America - 25.3% |
Bioprocessing analytics equipment demand accounts for 2.7% of the global biopharmaceutical equipment market. High demand for pharmaceutical manufacturing is expected to favour bioprocessing analytics equipment consumption over the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 4.54% |
H1, 2022 Projected | 4.55% |
H1, 2022 Outlook | 4.45% |
BPS Change - H1, 2022 (O) – H1, 2022 (P) | (-) 10 ↓ |
BPS Change – H1, 2022 (O) – H1, 2021 | (-) 09 ↓ |
As per the analysis by Future Market Insights, the variation between the BPS values observed within this market in H1, 2022 - outlook over H1, 2022 projected reflects a decline by 10 BPS. A decline in BPS growth in H1-2022 over H1-2021 by 09 Basis Point Share (BPS) is also demonstrated by the bioprocessing analytics equipment market.
The decline in the BPS values observed was attributed to the overall halt in the production and manufacturing capabilities during the mass lockdown impositions upon the advent of the global COVID-19 pandemic.
Conversely, through considerations in cost reduction during processes, consolidated bioprocessing approaches along with artificial intelligence and microfluidics are set to propel the process development in bioprocessing, thus promoting the growth of the overall industry.
The market is highly influenced by contract manufacturing dynamics, regulatory approvals, and licencing of therapeutics and biologics, under the impact of macro and industry factors. Key developments in the market include the development of Single-Use Systems (SUS) for bioprocessing, and bioremediation approaches for environmental sustainability.
Biomedical and biopharmaceutical industries have evolved exponentially over the past few years and increasing focus on creating better healthcare and medical ecosystem are expected to favor the demand for bioprocessing analytics equipment.
The market was valued at US$ 337 Mn and sales of bioprocessing analytics equipment rose at a CAGR of 4.1% for the market to attain a net valuation of US$ 463.2 Mn.
Rising demand for biotherapeutics, increasing demand for process optimization, rapid technological advancements, increasing research and development magnitude, and increasing scope of application in drug development and tissue engineering are some major factors that are expected to propel shipments of bioprocessing analytics equipment.
High cost of bioprocessing analytics equipment is expected to emerge as a major constraint in the global bioprocessing analytics equipment industry landscape. The demand for bioprocessing analytics equipment is projected to rise at a CAGR of 4.5% from 2022 to 2028.
“Increasing R&D and Drug Approvals to Fuel Market Growth Potential”
Research & development has seen an exponential increase over the past few years as the approval of new drugs has been increased by regulatory authorities such as the FDA (U.S. Food and Drug Administration). Increasing demand for the speedy development of new drugs and therapies has acted in favor of bioprocessing analytics equipment sales.
Increased research & development activity has encouraged bioprocessing analytics equipment manufacturers to launch new products to meet the increasing demand across the globe.
Since bioreactors have now become a staple in the bioprocessing industry, many companies have been rolling out new ones with larger capacities. The new bioreactors launched by Thermo Fisher are of capacities of 3000 liters and 5000 liters.
“High Costs and Stringent Regulatory Standards Majorly Hinder Market Growth”
High costs associated with bioprocessing analytics equipment are anticipated to be a major restraining factor in the global bioprocessing analytics equipment industry landscape. High costs restrict bioprocessing analytics equipment sales in less developed economies where spending potential is less.
Moreover, maintenance costs of bioprocessing analytics devices are also high which makes it even harder to afford while maintaining a budget for research and manufacturing operations.
Stringent regulatory norms and standards across the world make it difficult for bioprocessing analytics equipment manufacturers to create an evenly priced and distributed product for all. Which in turn creates an expensive product that is compliant with the standards of certain regions and countries. These factors are expected to restrain bioprocessing analytics equipment market potential.
“Increasing Focus on Healthcare to Drive Global Market Potential”
The bioprocessing analytics equipment industry analysis details the market stance across multiple regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
Sales of bioprocessing analytics equipment in North America account for a dominant market share of 25.3% in 2022. Presence of key bioprocessing analytics equipment companies and advanced facilities in the region are expected to propel bioprocessing analytics system demand through 2028.
Increasing instances of diseases in Europe have led to a rise in research and development activities in the region which subsequently drives bioprocessing analytics equipment sales. The market for bioprocessing analytics equipment in Western Europe and Eastern Europe currently accounts for 21.5% and 5.4% of the global landscape.
On a cumulative note, East Asia, South Asia, and the Pacific regions are anticipated to see notable growth in bioprocessing analytics equipment market potential over the forecast period. Increased focus on healthcare and rising research on biotherapeutics and other pharmaceutical applications in emerging economies such as India and China is expected to drive market expansion in the aforementioned regions.
Demand for bioprocessing analytics equipment in the MEA region is predicted to rise at a steady pace as focus on healthcare increases and investments towards R&D activities increase in the region. Bioprocessing analytics system shipments in the MEA region account for 6.4% share of the global marketplace.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Increasing Focus on Healthcare and Biotherapeutics to Favour Market Growth”
India provides an extremely lucrative setting for bioprocessing analytics equipment manufacturers as the nation has opportunities for manufacturing as well as distribution at very low costs compared to most developed nations. Government initiatives to attract foreign investments make India a lucrative manufacturing market for bioprocessing analytics equipment suppliers.
Rising focus on healthcare and a developing healthcare infrastructure fuel the demand for R&D activities which in turn increase bioprocessing analytics equipment sales.
“Rising Healthcare Expenditure to Fuel Demand for Bioprocessing Analytics Equipment”
The U.S. is one of the most prominent markets for bioprocessing analytics equipment in the world. The presence of major bioprocessing analytics equipment companies in this country is an extremely important factor that influences the consumption of bioprocessing analytics equipment.
Advanced healthcare infrastructure, high healthcare expenditure and spending, high availability of advanced facilities and technologies, high production of biotherapeutics are some major factors that propel bioprocessing analytics device sales in this nation.
“Bioprocessing Analytics Equipment in Industrial Applications Predicted to Have Dominant Outlook”
Increase in demand for pharmaceutical products and rising need to enhance the manufacturing process are fueling the use of bioprocessing analytics equipment in industrial applications. Bioprocessing analytics equipment enables industries to enhance their manufacturing processes and eliminates the possibilities of error that are common in manual bioprocess monitoring techniques.
Demand for bioprocessing analytics equipment in clinical application is also expected to rise at a steady pace with increase in research and development activities across the world.
The pandemic of 2020 bolstered the focus on healthcare and gave further impetus to the already popular biopharmaceutical industry. Sales of bioprocessing analytics equipment saw a drop in 2020 due to restricted manufacturing activity and disruptions in supply chains across the globe.
Shipments of bioprocessing analytics equipment are expected to bounce back in the post-pandemic era as the world returns to normalcy and manufacturing activities resume to their full capacity.
Bioprocessing analytics equipment manufacturers are investing in mergers and acquisitions to broaden their product offerings and boosts sales across multiple regions. Investments to develop advanced bioprocess monitoring equipment is expected to be a prominent trend as manual monitoring is prone to error and is very labour-intensive.
Attribute | Details |
---|---|
Forecast Period | 2022-2028 |
Historical Data Available for | 2013-2021 |
Market Analysis | US$ million for Value |
Key Regions Covered |
|
Key Countries Covered |
|
Key Market Segments Covered |
|
Key Companies Profiled |
|
Pricing | Available upon Request |
By Product Type :
By Application :
By End User :
By Region :
The global bioprocessing analytics equipment market rose at a CAGR of 4.1% and ended up with a valuation of US$ 463.2 Mn in 2021.
The bioprocessing analytics equipment market in Japan accounts for a market share of 7.6% in the global bioprocessing analytics equipment industry.
Bioprocessing analytics equipment sales are estimated to be worth US$ 633.6 Mn by the end of 2028.
Bioprocessing analytics equipment consumption is anticipated to rise at a CAGR of 4.5% from 2022 to 2028.
In 2022, the global bioprocessing analytics equipment market holds a valuation of US$ 485.1 Mn.
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Bioprocessing Analytics Equipment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Supply Side Drivers
4.1.1.2. Demand Side Drivers
4.1.2. Restraints
4.1.3. Trends
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2013 – 2021
6. Key Inclusions
6.1. Key Distributors List
6.2. Regulatory Scenario
6.3. Pricing Analysis
7. North America Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
7.3.1. U.S.
7.3.2. Canada
7.4. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021
7.4.1. Osmometers
7.4.1.1. Vapor Pressure Depression Osmometers
7.4.1.2. Membrane Osmometers
7.4.1.3. Freezing Point Depression Osmometers
7.4.2. Bioprocess Analyzers
7.5. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021
7.6.1. Clinical Application
7.6.2. Industrial Application
7.7. Market Size (US$ Mn) Forecast By Application, 2022–2028
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
7.8.1. Biopharmaceutical Companies
7.8.2. Contract Research Organizations (CROs)
7.8.3. Contract Manufacturing Organizations (CMOs)
7.8.4. Academics & Research Institutes
7.9. Market Attractiveness Analysis
7.9.1. By Country
7.9.2. By Product Type
7.9.3. By Application
7.9.4. By End User
7.10. Key Market Participants – Intensity Mapping
7.11. Drivers and Restraints: Impact Analysis
8. Western Europe Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028
8.1. Introduction
8.2. Regional Market Trends
8.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
8.3.1. Germany
8.3.2. U.K
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Western Europe
8.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
8.4.1. Germany
8.4.2. U.K
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Rest of Western Europe
8.5. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021
8.5.1. Osmometers
8.5.1.1. Vapor Pressure Depression Osmometers
8.5.1.2. Membrane Osmometers
8.5.1.3. Freezing Point Depression Osmometers
8.5.2. Bioprocess Analyzers
8.6. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028
8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021
8.7.1. Clinical Application
8.7.2. Industrial Application
8.8. Market Size (US$ Mn) Forecast By Application, 2022–2028
8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
8.9.1. Biopharmaceutical Companies
8.9.2. Contract Research Organizations (CROs)
8.9.3. Contract Manufacturing Organizations (CMOs)
8.9.4. Academics & Research Institutes
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.10.4. By End User
8.11. Key Market Participants – Intensity Mapping
8.12. Drivers and Restraints: Impact Analysis
9. Eastern Europe Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028
9.1. Introduction
9.2. Regional Market Trends
9.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
9.3.1. Russia
9.3.2. Poland
9.3.3. Rest of Eastern Europe
9.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
9.4.1. Russia
9.4.2. Poland
9.4.3. Rest of Eastern Europe
9.5. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021
9.5.1. Osmometers
9.5.1.1.1. Vapor Pressure Depression Osmometers
9.5.1.1.2. Membrane Osmometers
9.5.1.1.3. Freezing Point Depression Osmometers
9.5.2. Bioprocess Analyzers
9.6. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028
9.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021
9.7.1. Clinical Application
9.7.2. Industrial Application
9.8. Market Size (US$ Mn) Forecast By Application, 2022–2028
9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
9.9.1. Biopharmaceutical Companies
9.9.2. Contract Research Organizations (CROs)
9.9.3. Contract Manufacturing Organizations (CMOs)
9.9.4. Academics & Research Institutes
9.10. Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By End User
9.11. Key Market Participants – Intensity Mapping
9.12. Drivers and Restraints: Impact Analysis
10. Latin America Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Rest of Latin America
10.5. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021
10.5.1. Osmometers
10.5.1.1. Vapor Pressure Depression Osmometers
10.5.1.2. Membrane Osmometers
10.5.1.3. Freezing Point Depression Osmometers
10.5.2. Bioprocess Analyzers
10.6. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028
10.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021
10.7.1. Clinical Application
10.7.2. Industrial Application
10.8. Market Size (US$ Mn) Forecast By Application, 2022–2028
10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
10.9.1. Biopharmaceutical Companies
10.9.2. Contract Research Organizations (CROs)
10.9.3. Contract Manufacturing Organizations (CMOs)
10.9.4. Academics & Research Institutes
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By End User
10.11. Key Market Participants – Intensity Mapping
10.12. Drivers and Restraints: Impact Analysis
11. Asia Pacific Excluding China & Japan Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
11.3.1. India
11.3.2. Australia and New Zealand
11.3.3. ASEAN
11.3.4. Rest of APECJ
11.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
11.4.1. India
11.4.2. Australia and New Zealand
11.4.3. ASEAN
11.4.4. Rest of APECJ
11.5. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021
11.5.1. Osmometers
11.5.1.1. Vapor Pressure Depression Osmometers
11.5.1.2. Membrane Osmometers
11.5.1.3. Freezing Point Depression Osmometers
11.5.2. Bioprocess Analyzers
11.6. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028
11.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021
11.7.1. Clinical Application
11.7.2. Industrial Application
11.8. Market Size (US$ Mn) Forecast By Application, 2022–2028
11.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
11.9.1. Biopharmaceutical Companies
11.9.2. Contract Research Organizations (CROs)
11.9.3. Contract Manufacturing Organizations (CMOs)
11.9.4. Academics & Research Institutes
11.10. Market Attractiveness Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By End User
11.11. Key Market Participants – Intensity Mapping
11.12. Drivers and Restraints: Impact Analysis
12. China Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028
12.1. Introduction
12.2. Regional Trends
12.3. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021
12.3.1. Osmometers
12.3.1.1. Vapor Pressure Depression Osmometers
12.3.1.2. Membrane Osmometers
12.3.1.3. Freezing Point Depression Osmometers
12.3.2. Bioprocess Analyzers
12.4. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028
12.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021
12.5.1. Clinical Application
12.5.2. Industrial Application
12.6. Market Size (US$ Mn) Forecast By Application, 2022–2028
12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
12.7.1. Biopharmaceutical Companies
12.7.2. Contract Research Organizations (CROs)
12.7.3. Contract Manufacturing Organizations (CMOs)
12.7.4. Academics & Research Institutes
12.8. Market Attractiveness Analysis
12.8.1. By Product Type
12.8.2. By Application
12.8.3. By End User
12.9. Key Market Participants – Intensity Mapping
12.10. Drivers and Restraints: Impact Analysis
13. Japan Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028
13.1. Introduction
13.2. Regional Trends
13.3. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021
13.3.1. Osmometers
13.3.1.1. Vapor Pressure Depression Osmometers
13.3.1.2. Membrane Osmometers
13.3.1.3. Freezing Point Depression Osmometers
13.3.2. Bioprocess Analyzers
13.4. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028
13.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021
13.5.1. Clinical Application
13.5.2. Industrial Application
13.6. Market Size (US$ Mn) Forecast By Application, 2022–2028
13.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
13.7.1. Biopharmaceutical Companies
13.7.2. Contract Research Organizations (CROs)
13.7.3. Contract Manufacturing Organizations (CMOs)
13.7.4. Academics & Research Institutes
13.8. Market Attractiveness Analysis
13.8.1. By Product Type
13.8.2. By Application
13.8.3. By End User
13.9. Key Market Participants – Intensity Mapping
13.10. Drivers and Restraints: Impact Analysis
14. Middle East and Africa Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028
14.1. Introduction
14.2. Regional Market Trends
14.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of MEA
14.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of MEA
14.5. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021
14.5.1. Osmometers
14.5.1.1. Vapor Pressure Depression Osmometers
14.5.1.2. Membrane Osmometers
14.5.1.3. Freezing Point Depression Osmometers
14.5.2. Bioprocess Analyzers
14.6. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028
14.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021
14.7.1. Clinical Application
14.7.2. Industrial Application
14.8. Market Size (US$ Mn) Forecast By Application, 2022–2028
14.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021
14.9.1. Biopharmaceutical Companies
14.9.2. Contract Research Organizations (CROs)
14.9.3. Contract Manufacturing Organizations (CMOs)
14.9.4. Academics & Research Institutes
14.10. Market Attractiveness Analysis
14.10.1. By Country
14.10.2. By Product Type
14.10.3. By Application
14.10.4. By End User
14.11. Key Market Participants – Intensity Mapping
14.12. Drivers and Restraints: Impact Analysis
15. Forecast Factors: Relevance and Impact
16. Market Structure Analysis
16.1. Market Structure by Tier
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competitors Deep Dive
17.2.1. Thermo Fisher Scientific Inc.
17.2.1.1. Overview
17.2.1.2. Product and Application Portfolio
17.2.1.3. Production Footprint
17.2.1.4. Sales Footprint
17.2.1.5. Channel Footprint
17.2.1.6. Strategy
17.2.1.6.1.1. Marketing Strategy
17.2.1.6.1.2. Product Strategy
17.2.1.6.1.3. Channel Strategy
17.2.2. F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
17.2.2.1. Overview
17.2.2.2. Product and Application Portfolio
17.2.2.3. Production Footprint
17.2.2.4. Sales Footprint
17.2.2.5. Channel Footprint
17.2.2.6. Strategy
17.2.2.6.1.1. Marketing Strategy
17.2.2.6.1.2. Product Strategy
17.2.2.6.1.3. Channel Strategy
17.2.3. ELITechGroup
17.2.3.1. Overview
17.2.3.2. Product and Application Portfolio
17.2.3.3. Production Footprint
17.2.3.4. Sales Footprint
17.2.3.5. Channel Footprint
17.2.3.6. Strategy
17.2.3.6.1.1. Marketing Strategy
17.2.3.6.1.2. Product Strategy
17.2.3.6.1.3. Channel Strategy
17.2.4. KNAUER
17.2.4.1. Overview
17.2.4.2. Product and Application Portfolio
17.2.4.3. Production Footprint
17.2.4.4. Sales Footprint
17.2.4.5. Channel Footprint
17.2.4.6. Strategy
17.2.4.6.1.1. Marketing Strategy
17.2.4.6.1.2. Product Strategy
17.2.4.6.1.3. Channel Strategy
17.2.5. Gonotec GmbH
17.2.5.1. Overview
17.2.5.2. Product and Application Portfolio
17.2.5.3. Production Footprint
17.2.5.4. Sales Footprint
17.2.5.5. Channel Footprint
17.2.5.6. Strategy
17.2.5.6.1.1. Marketing Strategy
17.2.5.6.1.2. Product Strategy
17.2.5.6.1.3. Channel Strategy
17.2.6. Advanced Instruments Inc.
17.2.6.1. Overview
17.2.6.2. Product and Application Portfolio
17.2.6.3. Production Footprint
17.2.6.4. Sales Footprint
17.2.6.5. Channel Footprint
17.2.6.6. Strategy
17.2.6.6.1.1. Marketing Strategy
17.2.6.6.1.2. Product Strategy
17.2.6.6.1.3. Channel Strategy
17.2.7. Resolution Spectra Systems Inc.
17.2.7.1. Overview
17.2.7.2. Product and Application Portfolio
17.2.7.3. Production Footprint
17.2.7.4. Sales Footprint
17.2.7.5. Channel Footprint
17.2.7.6. Strategy
17.2.7.6.1.1. Marketing Strategy
17.2.7.6.1.2. Product Strategy
17.2.7.6.1.3. Channel Strategy
17.2.8. Kaiser Optical Systems, Inc.
17.2.8.1. Overview
17.2.8.2. Product and Application Portfolio
17.2.8.3. Production Footprint
17.2.8.4. Sales Footprint
17.2.8.5. Channel Footprint
17.2.8.6. Strategy
17.2.8.6.1.1. Marketing Strategy
17.2.8.6.1.2. Product Strategy
17.2.8.6.1.3. Channel Strategy
17.2.9. SYSBIOTECH SARL
17.2.9.1. Overview
17.2.9.2. Product and Application Portfolio
17.2.9.3. Production Footprint
17.2.9.4. Sales Footprint
17.2.9.5. Channel Footprint
17.2.9.6. Strategy
17.2.9.6.1.1. Marketing Strategy
17.2.9.6.1.2. Product Strategy
17.2.9.6.1.3. Channel Strategy
18. Global Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 By Region
18.1. Introduction / Key Findings
18.2. Historical Market Size (US$ Mn) Analysis By Region
18.2.1. North America
18.2.2. Western Europe
18.2.3. Eastern Europe
18.2.4. Latin America
18.2.5. Asia Pacific Excluding Japan And China
18.2.6. China
18.2.7. Japan
18.2.8. Middle East and Africa
18.3. Market Size (US$ Mn) Forecast By Region
18.3.1. North America
18.3.2. Western Europe
18.3.3. Eastern Europe
18.3.4. Latin America
18.3.5. Asia Pacific Excluding Japan And China
18.3.6. China
18.3.7. Japan
18.3.8. Middle East and Africa
18.4. Market Attractiveness Analysis By Region
19. Global Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028, By Product Type
19.1. Introduction/Key Finding
19.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021
19.2.1. Osmometers
19.2.1.1. Vapor Pressure Depression Osmometers
19.2.1.2. Membrane Osmometers
19.2.1.3. Freezing Point Depression Osmometers
19.2.2. Bioprocess Analyzers
19.3. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028
19.4. Market Attractiveness Analysis By Product Type
20. Global Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028, By Application
20.1. Introduction/Key Finding
20.2. Historical Market Size (US$ Mn) Analysis By Application, 2013-2021
20.2.1. Clinical Application
20.2.2. Industrial Application
20.3. Market Size (US$ Mn) Forecast By Application, 2022–2028
20.4. Market Attractiveness Analysis By Application
21. Global Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028, By End User
21.1. Introduction/Key Finding
21.2. Historical Market Size (US$ Mn) Analysis By End User, 2013-2021
21.2.1. Biopharmaceutical Companies
21.2.2. Contract Research Organizations (CROs)
21.2.3. Contract Manufacturing Organizations (CMOs)
21.2.4. Academics & Research Institutes
21.3. Market Size (US$ Mn) Forecast By End User, 2022–2028
21.4. Market Attractiveness Analysis By End User
22. Global Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028
22.1. Market Value Share Analysis By All Segment
22.2. Y-o-Y Growth Analysis By All Segment
22.3. Absolute $ Opportunity
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports